3-V Biosciences, Inc. - Product Market Growth & Opportunity - 2015

1
3-V Biosciences, Inc. - Product Pipeline Review -
2015
Published on October - 2015
2
.
Report Overview
About 3-V Biosciences, Inc. - Product Pipeline
Review - 2015 Research Beam added report on 3-V
Biosciences, Inc. Product Pipeline Review -
2015. Summary Global Markets Directs, 3-V
Biosciences, Inc. Product Pipeline Review -
2015, provides an overview of the 3-V
Biosciences, Inc. s 3-V Biosciences, Inc.
research and development focus. This report
provides comp rehensive information on the
current therapeutic developmental pipeline of 3-V
Biosciences, Inc. s, complete with comparative
analysis at various stages, therapeutics
assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule
type. It also reviews latest updates, and
featured news and press releases, along with
special features on late-stage and discontinued
projects. Get Full Details On
http//www.researchbeam.com/3-v-biosciences-inc-pr
oduct-pipeline-review-2015-market
3
.
Report Overview
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
Additionally, processes including live news
deals tracking, browser based alert-box and
clinical trials registries tracking ensure that
the most recent developments are captured on a
real time basis. The report enhances decision
making capabilities and help to create effective
counter strategies to gain competitive advantage.
It strengthens RD pipelines by identifying new
targets and MOAs to produce first-in-class and
best-in-class products. Note Certain sections
in the report may be removed or altered based on
the availability and relevance of data for the
indicated disease.
4
.
Report Overview
Scope The report provides brief overview of 3-V
Biosciences, Inc. including business
description, key information and facts, and its
locations and subsidiaries The report reviews
current pipeline of 3-V Biosciences, Inc. s
human therapeutic division and enlists all their
major and minor projects The report features
product description and descriptive mechanism of
action for key pipeline products along with the
products developmental history and major
milestones Special feature on out-licensed and
partnered product portfolio The report summarizes
all the dormant and discontinued pipeline
projects Latest company statement Latest news
and deals relating to the 3-V Biosciences, Inc.
s pipeline products  Reasons to buy  Evaluate 3-V
Biosciences, Inc. s strategic position with
total access to detailed information on its
product pipeline
5
Report Overview

• Assess the growth potential of 3-V Biosciences,
  Inc. in its therapy areas of focus
• Identify new drug targets and therapeutic classes
  in the 3-V Biosciences, Inc. s RD portfolio and
  develop key strategic initiatives to reinforce
  pipeline in those areas
• Exploit in-licensing opportunities by identifying
  windows of opportunity to fill portfolio gaps
• Develop strategic initiatives by understanding
  the focus areas of 3-V Biosciences, Inc. and
  exploit collaboration and partnership
  opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of 3-V
  Biosciences, Inc.
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  3-V Biosciences, Inc. and identify potential
  opportunities in those areas

6
Table Of Contents
Table of Contents 2List of Tables 4List of
Figures 43-V Biosciences, Inc. Snapshot 53-V
Biosciences, Inc. Overview 5Key Information
5Key Facts 53-V Biosciences, Inc. - Research
and Development Overview 6Key Therapeutic Areas
63-V Biosciences, Inc. - Pipeline Review
8Pipeline Products by Stage of Development
8Pipeline Products - Monotherapy 93-V
Biosciences, Inc. - Pipeline Products Glance
103-V Biosciences, Inc. - Clinical Stage
Pipeline Products 10
7
Table Of Contents
Phase I Products/Combination Treatment Modalities
103-V Biosciences, Inc. - Early Stage Pipeline
Products 11Preclinical Products/Combination
Treatment Modalities 113-V Biosciences, Inc. -
Drug Profiles 12TVB-2640 12Product Description
12Mechanism of Action 12RD Progress 12Small
Molecules to Inhibit Fatty Acid Synthase for
Oncology 13Product Description 13Mechanism of
Action 13RD Progress 13TVB-3567 14Product
Description 14
8
Table Of Contents
Mechanism of Action 14RD Progress 143-V
Biosciences, Inc. - Pipeline Analysis 153-V
Biosciences, Inc. - Pipeline Products by Target
153-V Biosciences, Inc. - Pipeline Products by
Route of Administration 163-V Biosciences, Inc.
- Pipeline Products by Molecule Type 173-V
Biosciences, Inc. - Pipeline Products by
Mechanism of Action 183-V Biosciences, Inc. -
Recent Pipeline Updates 193-V Biosciences, Inc.
- Dormant Projects 213-V Biosciences, Inc. -
Locations and Subsidiaries 22 Enquiry about this
report _at_ http//www.researchbeam.com/3-v-bioscienc
es-inc-product-pipeline-review-2015-market/enquire
-about-report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/3-v-biosciences-inc-pr
oduct-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com